The world-renowned diabetes researcher who announced his move last month from the University of Pittsburgh School of Medicine to the Allegheny Health Network has not taken all 19 Pitt researchers with him, as originally announced.
AHN said last month Massimo Trucco, the pediatric immunologist formerly based at Children’s Hospital of UPMC of Pittsburgh and working to cure Type 1 diabetes, would move to AHN to lead its newly created Institute for Cellular Therapeutics.
Alejandro Soto-Gutierrez, a Pitt assistant professor of pathology, and his research team of four transplant surgeons, a biologist and a pathologist, decided against the move. “We did not feel that it was a good fit for our research.” His focus is development of entire replacement organs.
Dr. Trucco is preparing to begin Phase II clinical trials to test his breakthrough treatment for Type 1 diabetes. AHN said, “Dr. Soto-Gutierrez’s decision not to join the network “does not alter in any way” its plans for “a world-class research program dedicated to the creation of innovative cell-based therapies.”
David Templeton: email@example.com or 412-263-1578.